Dr. Herbert C. Wolfsen, MD

Dr. Wolfsen practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Wolfsen's NPI, 1851380737, was assigned on October 13, 2005. Dr. Wolfsen graduated from Loma Linda University School Of Medicine in 1987. Dr. Wolfsen holds Florida license ME62940.

Dr. Wolfsen's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Wolfsen's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wolfsen practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Wolfsen's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Wolfsen is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Wolfsen's licenses on file in 5 states: Florida, Arizona, Georgia, Washington and Minnesota.

Dmand AI lists acid reflux, acute gastroduodenitis, colonoscopy, gastroduodenitis, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Wolfsen treats.

CMS data shows 407 Medicare services from Dr. Wolfsen across 11 procedure codes in 2024, for 301 Medicare patients. Medicare paid $39,252 for them.

CMS counts 301 Medicare patients who saw Dr. Wolfsen in 2024. The largest group is 65 to 74, with 144 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wolfsen's median patient age at 73, with 37% women.

In 2024, Dr. Wolfsen wrote 282 Medicare Part D claims for 105 patients. 99% of them were for generic drugs. CMS names the drug for 258 of them, across 6 drugs with 11 or more claims each, at $4,769 in total drug cost. In 2023, CMS named 270 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Wolfsen for performance year 2024, reported as part of a group. Dr. Wolfsen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wolfsen as offering telehealth. CMS counts 299 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Wolfsen, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 123 papers to Dr. Wolfsen, published from 2004 to 2024. 2020 was the busiest year, with 7. The most frequent topics are Barrett Esophagus, Esophageal Neoplasms and Esophagoscopy. Dr. Wolfsen has published most often in Gastrointest Endosc. Dr. Wolfsen's most frequent co-authors are Michael B. Wallace, MD, Massimo Raimondo, MD and Timothy Woodward, MD.

Dmand AI links Dr. Wolfsen to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Barrett Esophagus, Precancerous Conditions and Adenocarcinoma Of Esophagus.

CMS Open Payments shows 18 general payments to Dr. Wolfsen from 7 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Pinnacle Biologics, Inc paid the most, $5,139.

Dmand AI lists 2 awards for Dr. Wolfsen, most recently ACP Fellow in 1999.

Dr. Wolfsen graduated from Loma Linda University School Of Medicine in 1987. Dr. Wolfsen is a member of ACG and ACP.

Dr. Wolfsen is in network with 9 carriers, including Excellus BlueCross BlueShield, Aetna and Elevance. POS plans come from the most carriers, 5. Check the plan with the practice before a visit.